Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

Akebia Therapeutics (AKBA) shares are falling after the company announced the pricing of its secondary public offering at $8.25 per share. Akebia Therapeutics (AKBA) shares are falling after the ...

The spectrum of radiation visible to humans maxes out around 740nm, allowing the IR waves to remain undetected by normal observers. The project uses 940nm infrared (IR) LEDs embedded in clothes to ...

Inform your executive team, Board and corporate strategy while highlighting IR program success with real-time alerting, board-ready reports and Nasdaq proprietary analytics. Execute key IR program ...

CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2024, on ...

The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today... Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript May ...